Clopidogrel loading dose pre-PCI: How high?

Journal of Invasive Cardiology

Volumn 16, Issue 9, 2004, Pages 551-552

  Nikolsky, Eugenia ^a   Dangas, George ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; TICLOPIDINE;

BLEEDING; CORONARY STENT; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; HUMAN; LETTER; RISK ASSESSMENT; SIDE EFFECT; SURGICAL TECHNIQUE; THROMBOSIS;

DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; STENTS; THROMBOSIS; TICLOPIDINE;

EID: 4544323513     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (11)

1. Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995;91:1676-1688.
2. Bennett CL, Connors JM, Carwile JM, et al. Thrombotic thrombocytopenic purpura associated with clopidogrel. N Eng J Med 2000;342:1773-1777.
3. Bertrand ME, Rupprecht HJ, Urban P, et al. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: The Clopidogrel Aspirin Stent International Cooperative Study (CLASSICS). Circulation 2000;102:624-629.
4. Yusuf S, Zhao F, Mehta SR, et al. for the Clopidogrel in Unstable Angina to Prevent Recurrent Events Ttial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.
5. Mehta SR, Yusuf S, Peters RJ, et al. for the Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators. Lancet 2001;358:527-533.
6. Dangas G, Mehran R, Abizaid AS, et al. Combination therapy with aspirin plus clopidogrel versus aspirin plus ticlopidine for prevention of subacute thrombosis after successful native coronary stenting. Am J Cardiol 2001;87:470-472.
7. Moussa I, Oetgen M, Roubin G, et al. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis aftet coronary stent implantation. Circulation 1999;99:2364-2366.
8. Kastrati A, Mehilli J, Schuhlen H, et al. for the Intracoronary Stenting and Antithrombotic Regimen-Rapid Early Action for Coronary Treatment Study Investigators. A clinical triai of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel. N Engl J Med 2004;350:232-238.
9. Angiollilo DJ, Fernandez-Ortiz A, Bernardo E, et al. Is a 300 mg clopidogrel loading dose sufficient to inhibit platelet function early after coronary stenting? A platelet function profile study. J Invas Cardiol 2004;16:325-329.
10. Moussa I, Sofer D, Chui M, et al. What is the appropriate loading dose of clopidogrel prior to stent implantation? Insights from a platelet inhibition study. Am J Cardiol 1999;84(suppl 6A). Abstract TCT-182.
11. Steinhubl SR, Berger PB, Mann JT III, et al. for the CREDO Investigators. Clopidogrel for the Reduction of Events During Observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial. J Am Med Assoc 2002;288:2411-2420.